Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil

Lung Cancer. 2007 Apr;56(1):139-41. doi: 10.1016/j.lungcan.2006.11.020. Epub 2007 Jan 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Carcinoma, Signet Ring Cell / diagnosis
  • Carcinoma, Signet Ring Cell / drug therapy*
  • Carcinoma, Signet Ring Cell / radiotherapy
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Drug Combinations
  • Humans
  • Irinotecan
  • Male
  • Mediastinal Neoplasms / diagnosis
  • Mediastinal Neoplasms / drug therapy*
  • Mediastinal Neoplasms / radiotherapy
  • Middle Aged
  • Oxonic Acid / administration & dosage*
  • Tegafur / administration & dosage*
  • Tomography, X-Ray Computed

Substances

  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Irinotecan
  • Cisplatin
  • Camptothecin